These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35086669)

  • 1. Postinduction therapy pulmonary function retesting is necessary before surgical resection for non-small cell lung cancer.
    Connolly JG; Fiasconaro M; Tan KS; Cirelli MA; Jones GD; Caso R; Mansour DE; Dycoco J; No JS; Molena D; Isbell JM; Park BJ; Bott MJ; Jones DR; Rocco G
    J Thorac Cardiovasc Surg; 2022 Aug; 164(2):389-397.e7. PubMed ID: 35086669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer.
    Shin S; Choi YS; Jung JJ; Im Y; Shin SH; Kang D; Cho JH; Kim HK; Kim J; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Lee G; Cho J; Lee HY; Park HY
    Respir Res; 2020 Jan; 21(1):13. PubMed ID: 31924201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?
    Leo F; Solli P; Spaggiari L; Veronesi G; de Braud F; Leon ME; Pastorino U
    Ann Thorac Surg; 2004 Jan; 77(1):260-5; discussion 265. PubMed ID: 14726074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.
    Lopez Guerra JL; Gomez DR; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e537-43. PubMed ID: 22420964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early exercise pulmonary diffusing capacity of carbon monoxide after anatomical lung resection: a word of caution for fast-track programmes.
    Novoa NM; Esteban P; Gómez Hernández MT; Fuentes MG; Varela G; Jiménez MF
    Eur J Cardiothorac Surg; 2019 Jul; 56(1):143-149. PubMed ID: 30726898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.
    Rivera MP; Detterbeck FC; Socinski MA; Moore DT; Edelman MJ; Jahan TM; Ansari RH; Luketich JD; Peng G; Monberg M; Obasaju CK; Gralla RJ
    Chest; 2009 Jun; 135(6):1588-1595. PubMed ID: 19188545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Aug; 88(2):405-10; discussion 410-1. PubMed ID: 19632384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
    Takeda S; Funakoshi Y; Kadota Y; Koma M; Maeda H; Kawamura S; Matsubara Y
    Ann Thorac Surg; 2006 Jul; 82(1):232-6. PubMed ID: 16798220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%).
    Paul S; Andrews WG; Nasar A; Port JL; Lee PC; Stiles BM; Altorki NK
    Ann Am Thorac Soc; 2013 Dec; 10(6):616-21. PubMed ID: 24015712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron D; Jones DR; Daly BD; Starnes SL; Hatter JE; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):554-62. PubMed ID: 21724195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lung resection on exercise capacity and on carbon monoxide diffusing capacity during exercise.
    Wang JS; Abboud RT; Wang LM
    Chest; 2006 Apr; 129(4):863-72. PubMed ID: 16608931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.
    Lopez Guerra JL; Gomez D; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1573-9. PubMed ID: 22768989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
    Ferguson MK; Vigneswaran WT
    Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron DE; Jones DR; Daly BD; Starnes SL; Tan A; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1143-51. PubMed ID: 21872277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracoscopic lobectomy for non-small-cell lung cancer in patients with impaired pulmonary function: analysis from a national database.
    Bongiolatti S; Gonfiotti A; Vokrri E; Borgianni S; Crisci R; Curcio C; Voltolini L;
    Interact Cardiovasc Thorac Surg; 2020 Jun; 30(6):803-811. PubMed ID: 32249900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
    Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment optimization with pulmonary rehabilitation in lung cancer: Making the inoperable patients operable.
    Goldsmith I; Chesterfield-Thomas G; Toghill H
    EClinicalMedicine; 2021 Jan; 31():100663. PubMed ID: 33554075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
    Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
    Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
    Cerfolio RJ; Talati A; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):930-5; discussion 935-6. PubMed ID: 19699923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.